T.0340 Blood Transfusion Automation Managed Service Contract for Betsi Cadwaladr University Health Board

The procurement process for the extension of the T.0340 Blood Transfusion Automation Managed Service Contract for the Betsi Cadwaladr University Health Board is currently in the contract update stage. This contract, originally awarded in 2016 for a duration of 7 years with an additional 3-year extension, is due to expire in November 2026. The responsible authority for this procurement is the NHS Wales Shared Services Partnership-Procurement Services, hosted by Velindre University NHS Trust, based in Cardiff, United Kingdom.

The industry category for this tender is pathology services, and the services under this contract are to be delivered within the regions of North Wales. Delays related to the WLIMS system implementation necessitated extending current arrangements, following Regulation 72(c)(i) of PCR 2015, until the new tender process concludes. This tender presents significant growth opportunities for businesses in the pathology service industry, particularly those involved in blood transfusion automation.

Organisations capable of managing comprehensive and sensitive healthcare service contracts, such as large-scale diagnostics companies, could benefit from the opportunity to participate in future procurement processes related to this contract. Given the specialised nature of the services required, companies with a demonstrable track record in similar heavily-regulated environments will find themselves well-suited to meet the needs outlined by the Betsi Cadwaladr University Health Board as they prepare for the upcoming tender process. The current supplier, ORTHO-CLINICAL DIAGNOSTICS, exemplifies the level of expertise and reliability desired in this procurement area.